Academia is still not doing enough to make UK a leader in researchBMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c1466 (Published 15 March 2010) Cite this as: BMJ 2010;340:c1466
- Lynn Eaton
A major cultural shift is needed among medical academics if they are to work with the drug industry, a leading industry spokesman has claimed.
Malcolm Skingle, director of external science and technology at GlaxoSmithKline, was speaking at a conference of university medical academics in London on 11 March on promoting excellence in health research in the United Kingdom.
Although much has changed in recent years, some doctors still saw research funding from the industry as being “dirty money,” he said.
“They say it’s …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial